Yongmei Yin

28PUBLICATIONS
48CO-AUTHORS
Tumour immunologyMedical biotechnology diagnostics (incl. biosensors)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Apr 13, 2026
Precision immunotherapy for breast cancer: from biomarkers to clinical practice.

Jie Mei, Kai Yang, Xinkang Zhang

|Dec 12, 2025
Integrated Biomimetic Platform for Enhancing the Efficient Capture and Visual Identification of Circulating Tumor Cells.

Tianyu Zeng, Ben Li, Jialin Xu

|Aug 11, 2025
An open-label phase II study: The efficiency and safety of anlotinib + eribulin in patients with HER2-negative metastatic breast cancer.

Xinyu Wu, Fei Qu, Yijia Hua

|Apr 11, 2025
Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a randomized phase 3 trial.

Yongmei Yin, Ying Fan, Quchang Ouyang

|Apr 04, 2025
Enhanced the Trans-Cleavage Activity of CRISPR-Cas12a Using Metal-Organic Frameworks as Stimulants for Efficient Electrochemical Sensing of Circulating Tumor DNA.

Shuai Wu, Yincheng Liu, Tianyu Zeng

|Jun 26, 2024
Clinical, pathological and gene expression profiling of estrogen receptor discordance in breast cancer.

Xi Wang, Shengnan Bao, Mengping Jiang

Pageof 5

Frequent Collaborators

4 joint publications

Genxi Li

3 joint publications

Yongmei Yin

3 joint publications

Yan Liang

3 joint publications

Ningjun Duan